# Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing

> **NCT03166618** · NA · TERMINATED · sponsor: **Allergan** · enrollment: 1 (actual)

## Conditions studied

- Temple Hollowing

## Interventions

- **DEVICE:** Juvéderm® VOLUMA XC

## Key facts

- **NCT ID:** NCT03166618
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-24
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Business decision to stop the program.
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166618, "Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03166618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*